Remix Therapeutics is seeking a Director to translate commercial strategy into an actionable enterprise launch plan and align stakeholders around priorities and delivery. The Director will lead integrated launch management for the potential launch of REM-422, subject to regulatory approval, while functional leaders remain accountable for their respective strategies and deliverables. The role works across Commercial, Medical Affairs, Clinical Development, Regulatory, Market Access, Technical Operations, Quality, Finance, Legal and Compliance, IT, and Human Resources to connect workstreams, surface risks, and support timely leadership decisions. This is a hands-on leadership role requiring practical process-building, influence without direct authority, and the ability to move between strategic planning and detailed execution. Remix Therapeutics is a clinical-stage biotechnology company developing small molecule therapies designed to reprogram RNA processing. Its REMaster™ platform combines data science, biomolecular sciences, and chemistry to identify orally administered compounds that modulate gene expression. REM-422 is an investigational small molecule being evaluated in clinical programs for adenoid cystic carcinoma, acute myeloid leukemia, and high-risk myelodysplastic syndrome. The position is responsible for integrated planning, coordination, execution, and tracking of launch activities. The Director will establish practical governance and project management practices, maintain an integrated roadmap and risk register, facilitate decisions and cross-functional coordination, communicate readiness to leadership, and support readiness reviews and launch simulations.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director